Interfering with the IFN-γ/CXCL10 pathway to develop new targeted treatments for vitiligo

Ann Transl Med. 2015 Dec;3(21):343. doi: 10.3978/j.issn.2305-5839.2015.11.36.

Authors

Mehdi Rashighi¹, John E Harris¹

Affiliation

¹ Division of Dermatology, Department of Medicine, University of Massachusetts Medical School, Worcester, MA 01605, USA.

PMID: 26734651
PMCID: PMC4690998
DOI: 10.3978/j.issn.2305-5839.2015.11.36

No abstract available